Elevance Health I…
USUSDElevance Health Inc (LSE:0HG8) — Medical Specialities. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- elevancehealth.com
- Relaciones con los Inversores
- ir.elevancehealth.com/
- Sector
- Health Care · Medical Specialities
- Sede Central
- Indianapolis, United States
- Gestión
- Gail Boudreaux
- Últimos Informes
- anual 2025 ELEVANCE HEALTH INC 10K BOOKMARK 2026 VFINAL
- Empleados
- 96 129
- Fundada
- 1940
- Acciones en Circulación
- Capital Flotante
- 216.37 M
- Capitalización Bursátil
- 85.17 mil M USD
- Insiders
- 0.19%
- Inversores Institucionales
- 94.15%
- Industria (SIC)
- Hospital & Medical Service Plans
- Forma Jurídica
- R0BI
- ISIN
- US0367521038
- LEI
- 8MYN82XMYQH89CTMTH67
- P/E
- 15.6
- P/B
- 2.13
- Ratio de Reparto
- 29.2%
- FCF
- 6.51 mil M USD
- Pagos / FCF
- 23%
- Deuda
- 30.8 mil M USD3.1 a. de FCF
- Racha de Dividendos
- 15 a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.09.2026 (el último informe de la compañía).
- NAV
Descripción
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Dividendos
Elevance Health Inc (ELV) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 6.88 USD por acción (pagos: 4). Eso representa aproximadamente el 1.56% del precio actual de la acción. La próxima fecha ex-dividendo es el 04.12.2026: 1.72 USD por acción, con pago el 18.12.2026. Historial de dividendos ininterrumpido: 15 años.
| Fecha Ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-12-04 anunciado | 2026-12-18 | 1.7200 USD | 0.4/1.6 % | trimestral | US:ELV |
| 2026-09-10 | 2026-09-25 | 1.7200 USD | 0.4/1.7 % | trimestral | US:ELV |
| 2026-06-10 | 2026-06-25 | 1.7200 USD | 0.4/1.6 % | trimestral | US:ELV |
| 2026-03-10 | 2026-03-25 | 1.7200 USD | 0.6/2.4 % | trimestral | US:ELV |
| 2025-12-05 | 2025-12-19 | 1.7100 USD | 0.5/2.1 % | trimestral | US:ELV |
| 2025-09-10 | 2025-09-25 | 1.7100 USD | 0.5/2.1 % | trimestral | US:ELV |
| 2025-06-10 | 2025-06-25 | 1.7100 USD | 0.4/1.7 % | trimestral | US:ELV |
| 2025-03-10 | 2025-03-25 | 1.7100 USD | 0.4/1.6 % | trimestral | US:ELV |
| 2024-12-05 | 2024-12-20 | 1.6300 USD | 0.4/1.6 % | trimestral | US:ELV |
| 2024-09-10 | 2024-09-25 | 1.6300 USD | 0.4/1.4 % | trimestral | US:ELV |
| 2024-06-10 | 2024-06-25 | 1.6300 USD | 0.4/1.4 % | trimestral | US:ELV |
| 2024-03-07 | 2024-03-22 | 1.6300 USD | 0.4/1.4 % | trimestral | US:ELV |
| 2023-12-05 | 2023-12-21 | 1.4800 USD | 0.3/1.3 % | trimestral | US:ELV |
| 2023-09-07 | 2023-09-22 | 1.4800 USD | 0.3/1.3 % | trimestral | US:ELV |
| 2023-06-08 | 2023-06-23 | 1.4800 USD | 0.3/1.3 % | trimestral | US:ELV |
| 2023-03-09 | 2023-03-24 | 1.4800 USD | 0.3/1.2 % | trimestral | US:ELV |
| 2022-12-02 | 2022-12-21 | 1.2800 USD | 0.3/1.2 % | trimestral | US:ELV |
| 2022-09-08 | 2022-09-23 | 1.2800 USD | 0.3/1.1 % | trimestral | US:ELV |
| 2022-06-09 | 2022-06-24 | 1.2800 USD | 0.3/0.8 % | trimestral | US:ELV |
| 2022-03-09 | 2022-03-25 | 1.2800 USD | 0.3/0.5 % | trimestral | US:ELV |
| 2021-12-02 | 2021-12-21 | 1.1300 USD | 0.3/0.3 % | trimestral | US:ELV |
Noticias de Esta Semana
Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| Blackrock Inc. | 8.76% | 18.99 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.48% | 14.06 M | 2026-06-30 |
| State Street Corporation | 4.81% | 10.43 M | 2026-06-30 |
| Wellington Management Gr… | 4.25% | 9.21 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.05% | 6.61 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.87% | 6.21 M | 2026-06-30 |
| Sanders Capital, LLC | 2.69% | 5.83 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.49% | 5.39 M | 2026-06-30 |
| Geode Capital Management… | 2.38% | 5.17 M | 2026-06-30 |
| Harris Associates L.P. | 2.27% | 4.92 M | 2026-06-30 |
| Artisan Partners Limited… | 2.11% | 4.58 M | 2026-06-30 |
| Invesco Ltd. | 1.95% | 4.23 M | 2026-06-30 |
| VANGUARD WINDSOR FUNDS-V… | 1.4% | 3.04 M | 2026-07-31 |
| iShares Trust-iShares Co… | 1.33% | 2.89 M | 2026-08-31 |
| First Eagle Funds-First… | 1.31% | 2.84 M | 2026-07-31 |
| Fidelity Concord Street… | 1.29% | 2.81 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 2.66 M | 2026-08-31 |
| VANGUARD FENWAY FUNDS-Va… | 0.94% | 2.05 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.93% | 2.02 M | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.86 M | 2026-07-31 |
| BOUDREAUX GAIL A KOZIARA… | ≈0.08% | 172 036 | 2026-07-17 |
| BOUDREAUX GAIL KOZIARA (… | ≈0.08% | 169 311 | 2026-03-02 |
| NORWOOD FELICIA F. (Offi… | ≈0.02% | 38 838 | 2026-03-02 |
| KAYE MARK (Chief Financi… | ≈0.01% | 32 037 | 2026-03-02 |
| HAYTAIAN PETER D (Office… | ≈0.01% | 27 222 | 2026-03-02 |
| LAVU RATNAKAR (Chief Tec… | ≈0.01% | 16 149 | 2026-03-02 |
| HAY LEWIS III (Director) | ≈0.01% | 12 070 | 2026-05-13 |
| KENDRICK CHARLES MORGAN… | ≈0.01% | 11 791 | 2026-03-06 |
| PERU RAMIRO G (Director) | ≈0.01% | 10 908 | 2026-07-17 |
| DIXON ROBERT L JR (Direc… | ≈0% | 10 734 | 2026-06-11 |
